http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2398525-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b81a8f957691ddac8d015d1a8464b218 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9715ee42ca04792255166d73b4f79385 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d40960190e37af1e3390c21a67554f98 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4d2536d25c606cf230e24d4f94045e92 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-00 |
| filingDate | 2009-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2010-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43acf6da1e3accfc9851e502a87edfb9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_896378e1479f175252c7d668d1d5881c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34d3554c1b51507f10abaffd983f4891 |
| publicationDate | 2010-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2398525-C1 |
| titleOfInvention | Method of treating lung cancer |
| abstract | FIELD: medicine. ^ SUBSTANCE: invention relates to medicine, namely to oncology, and can be used for treatment of patients with lung cancer. Essence of the invention lies in the following: during operation after ligation and sewing vessels of lung root, in distal part of lung artery stump introduced and fixed is catheter through which chemical preparations cisplatin 50 mg/m2 and doxorubicin 50 mg/m2 are introduced into lung vessels. After that catheter is closed, incubating in this way chemical preparations with blood in lung during operation. After sewing main bronchus, lung is ablated, placed onto sterile tray, system for blood sampling is connected to catheter, blood from ablated lung is collected into sterile vial with glucigir and re-infused to patient intravenously by drop infusion. ^ EFFECT: application of invention allows to increase treatment efficiency due to application of auto-blood from ablated lung as medium for dissolving and introduction of chemical preparations and combination of their specific antitumour action with additional stimulation of immune system by present in said blood tumour agents, transformed by action of chemical preparations. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2506974-C1 |
| priorityDate | 2009-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 21.